What is the role of topical capsaicin (0.025 percent) in treating itching in patients with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topical Capsaicin 0.025% for ESRD Itching

Topical capsaicin 0.025% cream applied four times daily is an effective treatment for uremic pruritus in ESRD patients, with 82% of patients experiencing marked relief and 29% achieving complete remission, making it a valuable second-line option after optimizing dialysis parameters and basic skin care. 1, 2, 3

Treatment Algorithm for ESRD-Related Pruritus

First-Line: Optimize Dialysis and Basic Care

Before initiating capsaicin therapy, ensure the following fundamentals are addressed:

  • Dialysis adequacy: Target Kt/V of approximately 1.6, as pruritus is more common in underdialyzed patients 1, 2, 3
  • Metabolic control: Normalize calcium-phosphate balance and control parathyroid hormone levels to accepted ranges 1, 2, 3
  • Anemia correction: Use erythropoietin if anemia is present 2, 3
  • Emollients: Apply liberally for xerosis (dry skin), which lowers the threshold for itch even if not the primary cause 1, 3

Second-Line: Capsaicin or Gabapentin

When to choose capsaicin 0.025%:

  • Localized pruritus affecting specific body areas (back, face, arteriovenous fistula arm) 1
  • Patients who prefer topical over systemic therapy 1, 3
  • As adjunctive therapy with gabapentin for severe cases 3

Capsaicin dosing and efficacy:

  • Apply 0.025% cream to affected areas four times daily for at least 4 weeks 1, 2, 3
  • In the pivotal randomized, double-blind crossover trial, 14 of 17 patients (82%) reported marked relief, with 5 achieving complete remission 1, 4
  • Prolonged antipruritic effect lasting up to 8 weeks after cessation of treatment 1, 4
  • A separate trial using 0.03% concentration showed progressive improvement, with pruritus scores decreasing from 15.9 to 2.5 over 4 weeks (p<0.001) 5

Mechanism of action:

  • Capsaicin depletes substance P and other neuropeptides from peripheral sensory neurons, blocking pruritus transmission to the central nervous system 1, 4

Alternative Second-Line: Gabapentin (Preferred for Generalized Pruritus)

For generalized or severe pruritus, gabapentin 100-300 mg after each dialysis session (three times weekly) is the most effective systemic medication 2, 6, 3

  • These doses are significantly lower than non-ESRD populations due to reduced renal clearance 3
  • Common side effect is mild drowsiness 3

Important Considerations and Pitfalls

Side Effects of Capsaicin

  • Initial burning/stinging sensation is common but typically diminishes with continued use 4, 5
  • Mild cutaneous dryness or erythema may occur 4
  • No serious side effects reported in clinical trials 1, 4, 5
  • One patient in the original trial died of unrelated myocardial infarction 1

What NOT to Use

  • Avoid cetirizine: Specifically ineffective for uremic pruritus despite efficacy in other conditions 2, 6, 3
  • Avoid long-term sedating antihistamines (diphenhydramine, hydroxyzine): May predispose to dementia except in palliative care 2, 6, 3
  • Avoid calamine lotion: No literature supporting its use in uremic pruritus 3
  • Avoid crotamiton cream: Shown to be ineffective compared to vehicle control 3

Nuances in the Evidence

The evidence for capsaicin shows some interesting patterns:

  • Concentration matters: The 0.025% concentration used in the landmark trial 1, 4 is lower than the 0.05% concentration tested in experimental models, which showed less consistent results 7, 8, 9
  • Disease-specific efficacy: Capsaicin is highly effective for uremic pruritus but shows limited efficacy in atopic eczema and serotonin-induced itch 8, 9
  • Histamine vs. substance P: The success in uremic pruritus suggests substance P-mediated mechanisms rather than histamine-mediated pathways 4

Third-Line Options if Capsaicin Fails

  • Broad-band UVB phototherapy: Effective for many patients with strong supporting evidence 2, 3
  • Topical doxepin: Consider for severe cases, but strictly limit to 8 days, 10% body surface area, and maximum 12 grams daily 3
  • Renal transplantation: The only definitive cure but not always feasible 3

Practical Application

For a patient with ESRD and localized pruritus on the back and arms despite adequate dialysis (Kt/V 1.6) and regular emollient use, initiate capsaicin 0.025% cream four times daily to affected areas. Counsel the patient about initial burning sensation that typically resolves within days. Reassess at 2-4 weeks; if insufficient relief, consider adding gabapentin 100-300 mg post-dialysis or escalating to phototherapy. 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urticaria in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Pruritus in Chronic Kidney Disease (CKD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antihistamine Use in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lack of efficacy of topical capsaicin in serotonin-induced itch.

Skin pharmacology and applied skin physiology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.